Alzheimer's Disease: Efficacy of Mono- and Combination Therapy. A Systematic Review.

Additional memantine in combination with ChEI might be of slight benefit in patients with moderate to severe AD, but evidence is ambiguous. Longer trials are needed. No major cognitive benefit is missed, if solely appropriate ChEI monotherapy is initiated.